NCT01249352 2025-03-31
NICE
Eurofarma Laboratorios S.A.
Phase 2/3 Completed
Clinical Trials
11 trialsNCT01345084 2025-03-28
NICAP
Eurofarma Laboratorios S.A.
Phase 3 Withdrawn
NCT03413579 2021-08-25
CIMAHOPE
El Kendi Pharmaceuticals Manufacturing Company
Phase 3 Completed
NCT01813253 2018-03-26
Phase 3 Study of Nimotuzumab and Irinotecan as Second Line With Advanced or Recurrect Gastric and Gastroesophageal Junction Cancer
Kuhnil Pharmaceutical Co., Ltd.
Phase 3 Terminated
NCT00561990 2015-10-15
Nimotuzumab in Adults With Pancreatic Cancer
Oncoscience AG
Phase 2/3 Completed
NCT01301612 2014-07-14
Study of Nimotuzumab, Radiation Therapy and Cisplatin Versus Radiation Therapy and Cisplatin for Treatment of Stage IB e IVA UCC(CORUS)
Eurofarma Laboratorios S.A.
Phase 2 Withdrawn
NCT00600054 2011-07-06
Phase 2 Study of Nimotuzumab in Pediatric Recurrent Diffuse Intrinsic Pontine Glioma
YM BioSciences
Phase 2 Completed
NCT00369447 2011-07-01
A Study of Nimotuzumab in Combination With External Radiotherapy in Non-Small Cell Lung Cancer
YM BioSciences
Phase 1/2 Terminated
NCT00872482 2011-07-01
A Study of Nimotuzumab in Combination With Radiation Therapy in Patients With Brain Metastases
YM BioSciences
Phase 2 Terminated
NCT00493857 2008-11-17
Study of Nimotuzumab and Irinotecan in Metastatic Colorectal Cancer
YM BioSciences
Phase 2 Terminated
NCT00369252 2007-02-28
Phase I Study of Nimotuzumab in Solid Tumours
YM BioSciences
Phase 1 Completed